Paragon Private Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Paragon Private Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Buy	+1,493	New	+$202K	0.06%	213
2026 Q1	–	Sell	-1,644	Closed	-$200K	–	227
2025 Q4	$200K	Buy	+1,644	New	+$188K	0.06%	219
2025 Q1	–	Sell	-2,311	Closed	-$208K	–	196
2024 Q4	$208K	Sell	2,311 -191	-8%	-$18.5K	0.1%	163
2024 Q3	$247K	Hold	2,502	–	–	0.12%	148
2024 Q2	$232K	Sell	2,502 -89	-3%	-$7.98K	0.13%	142
2024 Q1	$246K	Hold	2,591	–	–	0.15%	127
2023 Q4	$231K	Sell	2,591 -485	-16%	-$36K	0.16%	124
2023 Q3	$225K	Hold	3,076	–	–	0.19%	114
2023 Q2	$256K	Hold	3,076	–	–	0.2%	109
2023 Q1	$234K	Hold	3,076	–	–	0.2%	114
2022 Q4	$255K	Hold	3,076	–	–	0.23%	111
2022 Q3	$248K	Hold	3,076	–	–	0.24%	100
2022 Q2	$228K	Hold	3,076	–	–	0.24%	94
2022 Q1	$213K	Hold	3,076	–	–	0.21%	104
2021 Q4	$344K	Buy	+3,076	New	+$371K	0.31%	81

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Paragon Private Wealth Management's XBI Position: Q2 2026 in Review

Paragon Private Wealth Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,493 shares worth $236K. The stake represents 0.06% of the portfolio and ranks #213 among its holdings. This is a return to the name: Paragon Private Wealth Management previously reported a position in XBI as recently as Q4 2025.

Paragon Private Wealth Management first reported a position in XBI in Q4 2021 and has held it in 15 quarters since. The position peaked at $344K in Q4 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Paragon Private Wealth Management held 1,493 shares of State Street SPDR S&P Biotech ETF worth $236K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Paragon Private Wealth Management position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.06% of Paragon Private Wealth Management's portfolio in Q2 2026, its #213 holding.
Paragon Private Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 15 quarters since.
Paragon Private Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $344K in Q4 2021.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Paragon Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.